INTRA CELLULAR THERAPIES INC shareholders Q3 2023

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 290 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

INTRA CELLULAR THERAPIES INC shareholders Q3 2023
NameSharesValueWeighting ↓
MILLENNIUM MANAGEMENT LLC 463,931$24,166,1660.01%
GEODE CAPITAL MANAGEMENT, LLC 1,911,022$99,557,2470.01%
FIRST HAWAIIAN BANK 6,893$359,0560.01%
JPMORGAN CHASE & CO 2,063,802$107,503,4480.01%
Squarepoint Ops LLC 84,194$4,385,6650.01%
VANGUARD GROUP INC 8,539,725$444,834,2760.01%
BlackRock Inc. 7,514,851$391,448,5900.01%
Arizona State Retirement System 24,581$1,280,4240.01%
STATE OF WISCONSIN INVESTMENT BOARD 70,403$3,667,2920.01%
ZACKS INVESTMENT MANAGEMENT 15,334$798,7290.01%
NORTHERN TRUST CORP 948,798$49,422,8880.01%
GPS Wealth Strategies Group, LLC 1,000$52,0900.01%
PUTNAM INVESTMENTS LLC 124,426$6,481,3500.01%
Crossmark Global Holdings, Inc. 8,199$4450.01%
VOYA INVESTMENT MANAGEMENT LLC 146,547$7,633,6330.01%
State of New Jersey Common Pension Fund D 52,422$2,730,6620.01%
BANK OF MONTREAL /CAN/ 453,883$26,751,8640.01%
Qube Research & Technologies Ltd 56,289$2,932,0940.01%
JENNISON ASSOCIATES LLC 186,867$9,733,9020.01%
CANADA PENSION PLAN INVESTMENT BOARD 105,400$5,490,2860.01%
External links

This page lists INTRA CELLULAR THERAPIES INC's shareholders in Q3 2023. To view INTRA CELLULAR THERAPIES INC's shareholder history, click here.